Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-014326 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
146,058
Total Value
$313,877.13
P&L
+inf% (+$2,976,140.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reporting Person's title: EVP, Chief Legal Officer | Common Stock | โ | Feb 27, 2026 | Grant/Award | 37,000 | $0.00 | $0.00 | 147,003 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Legal Officer | Common Stock | โ | Feb 27, 2026 | Sale | 3,325 | $27.95 | $92,933.75 | 143,678 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Legal Officer | Common Stock | โ | Mar 2, 2026 | Sale | 6,553 | $25.16 | $164,876.10 | 137,125 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Legal Officer | Common Stock | โ | Mar 2, 2026 | Sale | 193 | $25.91 | $5,001.38 | 136,932 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Legal Officer | Common Stock | โ | Mar 2, 2026 | Sale | 1,987 | $25.70 | $51,065.90 | 136,932 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Legal Officer | Stock Option (right to buy) | Derivative | Feb 27, 2026 | Grant/Award | 97,000 | $0.00 | $0.00 | 97,000 | Direct | โ | View Details |